Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Amortization of Deferred Charges: 2019-2024

Historic Amortization of Deferred Charges for Fennec Pharmaceuticals (FENC) over the last 5 years, with Dec 2024 value amounting to -$1.1 million.

  • Fennec Pharmaceuticals' Amortization of Deferred Charges fell 2012.73% to -$1.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $52,000, marking a year-over-year decrease of 76.47%. This contributed to the annual value of $52,000 for FY2024, which is 76.47% down from last year.
  • Fennec Pharmaceuticals' Amortization of Deferred Charges amounted to -$1.1 million in Q4 2024, which was down 449.50% from $301,000 recorded in Q3 2024.
  • Fennec Pharmaceuticals' 5-year Amortization of Deferred Charges high stood at $405,000 for Q2 2024, and its period low was -$1.1 million during Q4 2024.
  • For the 3-year period, Fennec Pharmaceuticals' Amortization of Deferred Charges averaged around $31,091, with its median value being $55,000 (2023).
  • Per our database at Business Quant, Fennec Pharmaceuticals' Amortization of Deferred Charges soared by 1,988.24% in 2020 and then tumbled by 2,012.73% in 2024.
  • Quarterly analysis of 5 years shows Fennec Pharmaceuticals' Amortization of Deferred Charges stood at $355,000 in 2020, then tumbled by 97.75% to $8,000 in 2021, then reached $55,000 in 2022, then remained steady at $55,000 in 2023, then crashed by 2,012.73% to -$1.1 million in 2024.
  • Its Amortization of Deferred Charges was -$1.1 million in Q4 2024, compared to $301,000 in Q3 2024 and $405,000 in Q2 2024.